BeStock  
Stocks › QDEL

QuidelOrtho QDEL

US equityMarket cap rank #3366
$12.25 −$0.06 (-0.49%)
Market open · Oct 8, 11:40 am ET · After hours $12.51 +1.62%
Open$12.26
Prev close$12.31
Day range$11.72 – $12.32
Volume428.7K
Market cap$840.05M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership121.8%-0.50 pts vs. prior quarter
Institutions holding286+0 vs. prior quarter
Insider trades (recent)43 buys / 7 sellsNet buying
Short interest20.69% of floatDays to cover 10.8 · as of 15 Sep 2026
Short-sale volume share16.3%5-day average of daily volume

Short-sale volume as % of daily volume

10%17%24%30%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$6.52M (5 inflow days, 15 outflow days).

Net flow by order size, last 20 sessions

−$3.5MSuper−$3.0MBig−$805.2KMid−$2.7MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 47.9% of shares outstanding.

Largest holders

  • BlackRock16.34%
  • FMR10.73%
  • Newtyn Management, LLC9.66%
  • Vanguard Portfolio Management, LLC6.03%
  • Vanguard Capital Management, LLC5.14%
  • Neuberger Berman Investment Advisers LLC4.93%
  • American Century Investment Management4.82%
  • Rubric Capital Management LP4.82%

By investor type

  • Mutual Fund94.29%
  • Hedge Fund21.54%
  • Public Company3.51%
  • Individual/Insider1.12%
  • Government Pension Fund0.97%
  • Private Company0.84%
  • Insurance Company0.34%
  • Family Office/Trust0.22%

Reported short interest has risen from 16.87% to 20.69% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Nuveen Asset Management LLC Insurance Company 2026/Q3 +184,116 0.3%
Newtyn Management, LLC Hedge Fund 2026/Q3 +2,066,528 9.7%
Paradigm Capital Management, Inc. Mutual Fund 2026/Q3 +995,800 3.7%
Buckley Capital Advisors, LLC Hedge Fund 2026/Q3 +850,335 1.2%
FMR Mutual Fund 2026/Q3 +770,795 10.7%
BlackRock Mutual Fund 2026/Q3 +753,396 16.3%
AQR Capital Management Hedge Fund 2026/Q3 +720,763 1.3%
Private Management Group Inc Mutual Fund 2026/Q3 +685,622 3.0%
Van Lanschot Kempen Investment Management N.V. Mutual Fund 2026/Q3 +647,069 0.9%
Gagnon Securities, LLC Mutual Fund 2026/Q3 +627,046 1.5%
American Century Investment Management Mutual Fund 2026/Q3 +450,947 4.8%
Millennium Management LLC Hedge Fund 2026/Q3 +440,263 1.1%
Eaton Vance Management Mutual Fund 2026/Q3 +344,141 0.7%
Morgan Stanley Public Company 2026/Q3 +307,874 1.7%
Gem Investment Advisors, LLC Mutual Fund 2026/Q3 +269,333 0.8%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
14 Sep 2026 Ronald Bowman Chief Human Resources Officer Derivative Exercise and Sale -921 $10.63 5,020
14 Sep 2026 Ronald Bowman Chief Human Resources Officer Derivative Exercise and Retained +1,645 – 5,020
14 Aug 2026 Bryan Hanson Senior Vice President of Clinical Labs & Transfusion Medicine Derivative Exercise and Sale -162 $14.30 8,055
14 Aug 2026 Bryan Hanson Senior Vice President of Clinical Labs & Transfusion Medicine Derivative Exercise and Retained +284 – 8,055
14 Jul 2026 Micah Young Chief Financial Officer & Principal Financial Officer Other Derivative Acquisition +356,555 – 356,555
30 Jun 2026 Bryan Hanson Senior Vice President of Clinical Labs & Transfusion Medicine Derivative Exercise and Sale -2,096 $18.18 7,771
30 Jun 2026 Bryan Hanson Senior Vice President of Clinical Labs & Transfusion Medicine Derivative Exercise and Retained +3,701 – 7,771
24 Jun 2026 Ann Rhoads Independent Director Other Derivative Acquisition +369 – 369
24 Jun 2026 Ann Rhoads Independent Director Other Derivative Acquisition +3,698 – 3,698
24 Jun 2026 Ann Rhoads Independent Director Other Derivative Acquisition +15,532 – 15,532
24 Jun 2026 Kenneth Widder Independent Director Other Derivative Acquisition +1,997 – 1,997
24 Jun 2026 Kenneth Widder Independent Director Other Derivative Acquisition +6,656 – 6,656
24 Jun 2026 Kenneth Widder Independent Director Other Derivative Acquisition +15,532 – 15,532
24 Jun 2026 Kenneth Buechler Independent Non-Executive Chairperson Other Derivative Acquisition +3,661 – 3,661
24 Jun 2026 Kenneth Buechler Independent Non-Executive Chairperson Other Derivative Acquisition +12,204 – 12,204
24 Jun 2026 Kenneth Buechler Independent Non-Executive Chairperson Other Derivative Acquisition +15,532 – 15,532
24 Jun 2026 Edward Michael Independent Director Other Derivative Acquisition +1,053 – 1,053
24 Jun 2026 Edward Michael Independent Director Other Derivative Acquisition +3,513 – 3,513
24 Jun 2026 Edward Michael Independent Director Other Derivative Acquisition +15,532 – 15,532
24 Jun 2026 Mary Polan Independent Director Other Derivative Acquisition +1,664 – 1,664

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 14,190,525 20.7% 10.8
31 Aug 2026 14,128,210 20.6% 10.5
14 Aug 2026 14,962,267 21.8% 7.6
31 Jul 2026 13,005,131 19.1% 12.7
15 Jul 2026 11,802,749 17.3% 9.8
30 Jun 2026 11,505,504 16.9% 5.4

Discussion

No comments yet — be the first to weigh in on QDEL.

Leave a comment

Scroll to Top